Get my own profile
Public access
View all1 article
2 articles
available
not available
Based on funding mandates
Co-authors
- Gerard DrewesCellzome/GlaxoSmithKline R&DVerified email at gsk.com
- Marcus BantscheffCellzome, a GSK companyVerified email at gsk.com
- Mikhail SavitskiEMBLVerified email at embl.de
- Holger FrankenGSKVerified email at holgerfranken.de
- Colin Louis MastersThe University of MelbourneVerified email at florey.edu.au
- Dirk EberhardThoraxklinik-Heidelberg gGmbHVerified email at med.uni-heidelberg.de
- Wolfgang HuberEMBL - European Molecular Biology LaboratoryVerified email at embl.org
- Bernhard KusterProfessor for Proteomics and BioanalyticsVerified email at tum.de
- Daniel Martinez MolinaCSO at Pelago Bioscience, SwedenVerified email at pelagobio.com
- Par NordlundKarolinska InstitutetVerified email at ki.se
- Susan KlaegerGenentech Inc.Verified email at gene.com
- Stephan GadeCellzome, a GSK companyVerified email at gsk.com
- Maciej Zamek-GliszczynskiSenior Fellow and Director, Drug Metabolism and Pharmacokinetics, GlaxoSmithKlineVerified email at gsk.com
- H. Christian EberlCellzome GmbH, a GSK companyVerified email at gsk.com
- David Harold DrewryProfessor University of North Carolina Chapel HillVerified email at unc.edu